These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8116686)

  • 1. Hormonal modulation of proteinuria in the nephrotic syndrome.
    Hutchison FN
    Am J Nephrol; 1993; 13(5):337-46. PubMed ID: 8116686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinuria and albumin homeostasis in the nephrotic syndrome: effect of dietary protein intake.
    Rodrigo R; Bravo I; Pino M
    Nutr Rev; 1996 Nov; 54(11 Pt 1):337-47. PubMed ID: 9110562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
    Tesar V; Zima T; Jirsa M; Crkovská J; Stípek S; Vernerová Z; Seráková M
    Cas Lek Cesk; 1999 Oct; 138(18):560-4. PubMed ID: 10596472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-proteinuria effects of nonsteroidal anti-inflammatory drugs in patients with nephrotic syndrome: an illusion or a read improvement?].
    Stosić Z; Sedlak V; Felle D; Curić S; Ubavić M; Vodopivec S
    Med Pregl; 1995; 48(5-6):155-8. PubMed ID: 7565334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinuria, hyperlipidemia, and the kidney.
    Hutchison FN
    Miner Electrolyte Metab; 1993; 19(3):127-36. PubMed ID: 8232099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotic edema--pathogenesis and treatment.
    Palmer BF
    Am J Med Sci; 1993 Jul; 306(1):53-67. PubMed ID: 8328511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits and risks of nonsteroidal antiinflammatory drugs in steroid-resistant nephrotic syndrome.
    Velosa JA; Torres VE
    Am J Kidney Dis; 1986 Nov; 8(5):345-50. PubMed ID: 3788972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between hyperlipidemia, lipid mediators, and progressive glomerulosclerosis in the nephrotic syndrome.
    Kees-Folts D; Diamond JR
    Am J Nephrol; 1993; 13(5):365-75. PubMed ID: 8116689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic management of adult idiopathic nephrotic syndrome.
    Alaniz C; Brosius FC; Palmieri J
    Clin Pharm; 1993 Jun; 12(6):429-39. PubMed ID: 8403814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome.
    Tesar V; Zima T; Jirsa M; Crkovská J; Stípek S; Vernerová Z; Seráková M
    Med Sci Monit; 2002 Feb; 8(2):BR69-74. PubMed ID: 11859270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular preload and afterload reduction as a tool to lower urinary protein leakage: will such treatments also help to improve renal function outcome?
    de Jong PE; Anderson S; de Zeeuw D
    J Am Soc Nephrol; 1993 Jan; 3(7):1333-41. PubMed ID: 8439644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum adiponectin levels during steroid-responsive nephrotic syndrome relapse.
    Bakkaloglu SA; Soylemezoglu O; Buyan N; Funahashi T; Elhan AH; Peru H; Fidan K; Yilmaz S; Hasanoglu E
    Pediatr Nephrol; 2005 Apr; 20(4):474-7. PubMed ID: 15690190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of nonsteroidal anti-inflammatory drugs on glomerular filtration of proteins and their therapeutic utility.
    Remuzzi A; Remuzzi G
    Semin Nephrol; 1995 May; 15(3):236-43. PubMed ID: 7631050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
    Nakhoul F; Ramadan R; Khankin E; Yaccob A; Kositch Z; Lewin M; Assady S; Abassi Z
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
    Pedraza-Chaverrí J; Cruz C; Ibarra-Rubio ME; Chávez MT; Calleja C; Tapia E; del Carmen Uribe M; Romero L; Peña JC
    Rev Invest Clin; 1990; 42(1):29-38. PubMed ID: 2236972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat.
    Davies RW; Staprans I; Hutchison FN; Kaysen GA
    J Clin Invest; 1990 Aug; 86(2):600-5. PubMed ID: 2384606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathophysiology of edema formation in the nephrotic syndrome.
    Siddall EC; Radhakrishnan J
    Kidney Int; 2012 Sep; 82(6):635-42. PubMed ID: 22718186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there any reason to lower proteinuria in a child with nephrotic-range proteinuria who is not clinically edematous?
    Kees-Folts D
    Pediatr Nephrol; 1996 Apr; 10(2):180. PubMed ID: 8703706
    [No Abstract]   [Full Text] [Related]  

  • 19. The changing face of childhood nephrotic syndrome.
    Chesney R
    Kidney Int; 2004 Sep; 66(3):1294-302. PubMed ID: 15327442
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
    Kaysen GA; Davies RW
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S75-9. PubMed ID: 16989070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.